In 1992, a University of Rochester pharmacologist named Michael Weintraub published a study on a drug combination that appeared to produce never-before-seen weight loss. By week 34, his subjects — 121 volunteers — lost, on average, 30 pounds. What’s more, they rated the fenfluramine-plus-phentermine regimen not only more helpful than placebo, but also not terribly “bothersome.” The tiny study… Read More »
Protein power The research team set out to create their blood-based test by identifying a signature set of biomarkers in patients’ blood that consistently indicated a high likelihood of ATB, then developing an easily deployable assay that could detect that signature. They first measured the levels of 47 different blood proteins in about 400 samples… Read More »
September 26, 2019 Posted By Categories Gary Schwitzer is the founder and publisher of HealthNewsReview.org. He tweets as @garyschwitzer, or at @HealthNewsRevu. For the past 11 years, HealthNewsReview.org has helped journalists find industry-independent experts to use as sources in their stories. It’s an effort begun by journalists Jeanne Lenzer and Shannon Brownlee (now a VP… Read More »
By Michael Le Page A new cancer treatments works by by hurting fast-dividing cellsOksana Krasiuk / Alamy Stock Photo Many cancer treatments work very well in the beginning only to fail later as tumours evolve resistance. But a new generation of therapies are being developed to prevent this. One, called BOS172722, has been shown in… Read More »